MDMA, commonly referred to as ecstasy, molly, or xtc, has always had a reputation for being a party drug. It’s a part of the amphetamine family and can produce enhanced and heightened emotions. Over the last few years, studies have increasingly found that MDMA can be used to treat PTSD. These studies have given MDMA a new life for the perception of the drug.
The Multidisciplinary Association for Psychedelic Studies (MAPS) has opened up five clinical trials in four states. These trials are designed to help people who suffer from PTSD. They have open applications to submit your name for potential MDMA-assisted psychotherapy. Scientists are seeking participants so they can complete the last phase. After that, U.S. Food and Drug Administration will be able to approve the drug for medical use.
“If the Phase 3 trials demonstrate significant efficacy and an acceptable safety profile, FDA approval is expected by 2021.” – MAPS
The following five trial sites open for enrollment are located in:
- North Hollywood, California
- Boulder, Colorado
- Fort Collins, Colorado
- New Orleans, Louisiana
- Mount Pleasant, South Carolina
If everything goes well, there’s potential for the clinical sites locations to rise to 14. New York and Boston would get a few, and some would even spread to Canada and Israel.
For more information, you can go to the website and see if you are eligible.